The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea
Abstract Background Bile acid diarrhoea (BAD) can be severely debilitating and negatively affect patients’ quality of life (QoL). We carried out a multi-centre prospective study exploring QoL outcomes in patients with BAD after treatment with colesevelam. Methods Patients with or without a positive...
Main Authors: | Aditi Kumar, Niall Galbraith, Hafid O. Al-Hassi, Manushri Jain, Oliver Phipps, Jeffrey Butterworth, Helen Steed, John McLaughlin, Matthew J. Brookes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-022-02404-9 |
Similar Items
-
The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
by: Aditi Kumar, et al.
Published: (2023-03-01) -
Bile acid diarrhoea and metabolic changes after cholecystectomy: a prospective case-control study
by: Alexia Farrugia, et al.
Published: (2024-08-01) -
Cholestyramine treatment in two dogs with presumptive bile acid diarrhoea: a case report
by: L. Toresson, et al.
Published: (2021-01-01) -
SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis
by: Marie Westwood, et al.
Published: (2022-11-01) -
High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
by: Mohamed G. Shiha, et al.
Published: (2020-08-01)